← FDA Drug Approvals (Drugs@FDA)
DECITABINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RELIANCE LIFE SCI · Approved 2025-12-19
Drug application
- FDA Application #
ANDA217814- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DECITABINE
- Generic name
- Decitabine
- Active ingredients
- DECITABINE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- RELIANCE LIFE SCI
- First approval
- 2025-12-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown